Patents by Inventor Steven P. Stoesz

Steven P. Stoesz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunohistochemical detection assay for carcinoma proliferative status
    Patent number: 5846739
    Abstract: A method of determining the proliferative status of a carcinoma is disclosed. One obtains a patient sample and then quantitatively analyzes the sample for NGAL gene expression product. The amount of NGAL expression product is compared with a standard curve to determine the S-phase value. The sample can be breast tissue or breast fluid aspirate. Alternatively, blood can by analyzed for this marker to diagnose metastasis.
    Type: Grant
    Filed: January 6, 1997
    Date of Patent: December 8, 1998
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Michael N. Gould, Steven P. Stoesz
  • Assay for carcinoma proliferative status by measuring NGAL expression level
    Patent number: 5627034
    Abstract: A method of determining the proliferative status of a carcinoma is disclosed. One obtains a patient sample and then quantitatively analyzes the sample for NGAL gene expression product. The amount of NGAL expression product is compared with a standard curve to determine the S-phase value. The sample can be breast tissue or breast fluid aspirate. Alternatively, blood can by analyzed for this marker to diagnose metastasis.
    Type: Grant
    Filed: December 5, 1995
    Date of Patent: May 6, 1997
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Michael N. Gould, Steven P. Stoesz